CN112047883B - Preparation method of atracurium besylate - Google Patents
Preparation method of atracurium besylate Download PDFInfo
- Publication number
- CN112047883B CN112047883B CN201910491476.2A CN201910491476A CN112047883B CN 112047883 B CN112047883 B CN 112047883B CN 201910491476 A CN201910491476 A CN 201910491476A CN 112047883 B CN112047883 B CN 112047883B
- Authority
- CN
- China
- Prior art keywords
- pentanediol
- preparation
- acid
- refined
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/88—Separation; Purification; Use of additives, e.g. for stabilisation by treatment giving rise to a chemical modification of at least one compound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical Field
本发明属于药物化学和化学合成领域,具体涉及顺苯磺酸阿曲库铵及其制备方法和用途。The invention belongs to the field of pharmaceutical chemistry and chemical synthesis, and particularly relates to atracurium besylate and a preparation method and application thereof.
背景技术Background technique
苯磺顺阿曲库铵无明显组胺释放,肌松作用小,无蓄积作用,且心血管的反应小,对肝、肾等脏器功能的依赖也小,是较为理想的中时效非去极化肌松药。Cisatracurium besylate has no obvious histamine release, little muscle relaxant effect, no accumulation effect, and little cardiovascular response. It also has little dependence on the functions of organs such as the liver and kidneys. It is an ideal medium-acting non-depolarizing muscle relaxant.
苯磺顺阿曲库铵的多种合成方法已经被公开报道。WO9200965报道了R-四氢罂粟碱与二丙烯酸戊二醇酯发生加成反应,然后游离,进一步与苯磺酸甲酯反应得到苯磺酸阿曲库铵,最后柱层析拆分得到顺式苯磺酸阿曲库铵。Various synthesis methods of cisatracurium besylate have been publicly reported. WO9200965 reported that R-tetrahydropapaverine reacts with pentanediol diacrylate to undergo addition reaction, then is liberated, and further reacts with methyl benzenesulfonate to obtain atracurium besylate, and finally column chromatography is performed to obtain cis-atracurium besylate.
WO2009007946公开了另一种合成方法,单胺丙酸叔丁酯与苯磺酸甲酯反应,生成单胺丙酸叔丁酯季铵盐,然后拆分得到顺式单胺丙酸叔丁酯季铵盐,然后水解得到单胺丙酸季铵盐,继续与戊二醇反应得到产物顺式苯磺酸阿曲库铵,也可以将单胺丙酸季铵盐与戊二醇反应得到顺式单胺丙酸戊二醇酯,最后再与另一分子的单胺丙酸季铵盐缩合得到产物顺式苯磺酸阿曲库铵。WO2009007946 discloses another synthesis method, wherein monoamine propionate tert-butyl ester reacts with methyl benzenesulfonate to generate monoamine propionate tert-butyl ester quaternary ammonium salt, which is then split to obtain cis-monoamine propionate tert-butyl ester quaternary ammonium salt, which is then hydrolyzed to obtain monoamine propionate quaternary ammonium salt, which is then further reacted with pentanediol to obtain the product cis-atracurium benzenesulfonate. The monoamine propionate quaternary ammonium salt can also be reacted with pentanediol to obtain cis-monoamine propionate pentanediol ester, which is then condensed with another molecule of monoamine propionate quaternary ammonium salt to obtain the product cis-atracurium benzenesulfonate.
以上专利中使用的原料均为市场上购得的原料。目前市场上可获得的、能用于工业规模制备产品的戊二醇中含有多种杂质,主要杂质是1,6-己二醇、1-甲基戊二醇、2-甲基戊二醇、3-甲基戊二醇等。这些具有化学活性的杂质在苯磺酸的催化下能与原料化合物II发生缩合反应,生成杂质,这些杂质与产物的性质接近,不易于纯化。The raw materials used in the above patents are all purchased from the market. The pentanediol currently available on the market and used for industrial-scale preparation of products contains a variety of impurities, the main impurities being 1,6-hexanediol, 1-methylpentanediol, 2-methylpentanediol, 3-methylpentanediol, etc. These chemically active impurities can undergo condensation reaction with the raw material compound II under the catalysis of benzenesulfonic acid to generate impurities, which are similar in nature to the product and are not easy to purify.
WO2009007946报道的合成方法有一些值得注意的问题。具体而言,缩合单胺丙酸季铵盐原料转化不完全,剩余的原料不易于纯化;市场可以购买得到的原料戊二醇中常含有能参与反应的杂质,导致质含量偏高,需要复杂纯化步骤才能得到合格产品,且产品质量不稳定;各种杂质的纯化过程需要耗费大量溶剂,造成污染。以上问题在工业生产中会更加严重性突显出来。The synthesis method reported in WO2009007946 has some problems worth noting. Specifically, the conversion of the condensed monoamine propionic acid quaternary ammonium salt raw material is incomplete, and the remaining raw material is not easy to purify; the raw material pentanediol available on the market often contains impurities that can participate in the reaction, resulting in a high content of impurities, requiring complex purification steps to obtain qualified products, and the product quality is unstable; the purification process of various impurities requires a large amount of solvents, causing pollution. The above problems will be more serious in industrial production.
因此,开发高转化率制备高纯度顺式苯磺酸阿曲库铵的新方法就显得尤为重要,也需要开发精制原料戊二醇的方法,并且新方法需要满足ESH管理体系的要求,符合安全环保绿色合成的更高追求和理念。Therefore, it is particularly important to develop a new method for preparing high-purity cis-atracurium besylate with high conversion rate. It is also necessary to develop a method for refining the raw material pentanediol. In addition, the new method needs to meet the requirements of the ESH management system and conform to the higher pursuit and concept of safe, environmentally friendly and green synthesis.
发明目的Purpose of the Invention
为了解决现有技术中的不足,本发明属于药物化学和化学合成领域,具体涉及苯磺酸顺阿曲库铵的制备方法。In order to solve the deficiencies in the prior art, the present invention belongs to the field of pharmaceutical chemistry and chemical synthesis, and specifically relates to a preparation method of cisatracurium besylate.
技术方案Technical solutions
为了实现上述目的,本发明提供一种结构式I表示的苯磺酸顺阿曲库铵的制备方法,该方法通过以下反应式实现:In order to achieve the above object, the present invention provides a method for preparing cisatracurium besylate represented by structural formula I, which is achieved by the following reaction formula:
该方法包括以下步骤:The method comprises the following steps:
将式III表示的精制1,5-戊二醇与式II表示的化合物、式IV表示的催化剂苯磺酸一水合物溶解于有机溶剂中,发生缩合反应,得到式I表示的顺苯磺酸阿曲库铵。The purified 1,5-pentanediol represented by formula III, the compound represented by formula II, and the catalyst benzenesulfonic acid monohydrate represented by formula IV are dissolved in an organic solvent to undergo a condensation reaction to obtain cis-atracurium benzenesulfonate represented by formula I.
优选地,上述缩合反应所用的有机溶剂选自二氯甲烷、氯苯、甲苯、二甲苯、乙酸乙酯、乙酸甲酯、乙酸丙酯、乙酸丁酯、四氢呋喃、2-甲基四氢呋喃、1,4-二氧六环、乙二醇二甲醚、二乙二醇二甲醚、乙腈、丙酮或丁酮中的一种或几种的混合物。Preferably, the organic solvent used in the above condensation reaction is selected from one or a mixture of dichloromethane, chlorobenzene, toluene, xylene, ethyl acetate, methyl acetate, propyl acetate, butyl acetate, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, acetonitrile, acetone or butanone.
优选地,所述缩合反应的反应温度为30-160摄氏度,进一步优选地,在反应混合物或回流分水装置中加入干燥剂。Preferably, the reaction temperature of the condensation reaction is 30-160 degrees Celsius. Further preferably, a desiccant is added to the reaction mixture or the reflux water separation device.
更优选地,所用的有机溶剂为二氯甲烷;更优选地,所述缩合反应的反应温度为二氯甲烷回流温度。更优选地,反应器装配回流分水装置,在回流分水装置中加入分子筛、硫酸钠、硫酸镁、氯化钙、硅胶中的一种或多种的混合物作为干燥剂。More preferably, the organic solvent used is dichloromethane; more preferably, the reaction temperature of the condensation reaction is the reflux temperature of dichloromethane. More preferably, the reactor is equipped with a reflux water separation device, and a mixture of one or more of molecular sieves, sodium sulfate, magnesium sulfate, calcium chloride, and silica gel is added to the reflux water separation device as a desiccant.
反应完毕后,冷却到室温,先用水洗去苯磺酸及水溶性杂质,二氯甲烷层减压浓缩至小体积,滴加入有机溶剂中,析出固体,过滤,烘干,即可得到高纯度顺苯磺酸阿曲库铵。After the reaction is completed, the mixture is cooled to room temperature, benzenesulfonic acid and water-soluble impurities are washed away with water, the dichloromethane layer is concentrated to a small volume under reduced pressure, and then added dropwise to an organic solvent to precipitate a solid, which is then filtered and dried to obtain high-purity atracurium besylate.
上述纯化过程所用有机溶剂选自甲苯、环己烷,二甲苯、氯苯、正己烷、石油醚、正庚烷、甲基叔丁基醚、异丙醚、正丁醚、乙醚、四氢呋喃、甲基四氢呋喃、乙酸乙酯、甲酸甲酯、甲酸乙酯、乙酸甲酯、乙酸异丙酯、乙酸叔丁酯、乙酸丁酯、丙酸乙酯、丙酸甲酯、苯甲酸甲酯、氯代丁烷、氯代戊烷、氯代环戊烷、氯代己烷、氯代环己烷、丙酮、丁酮、戊酮、环己酮等中的一种或几种的混合物。The organic solvent used in the above purification process is selected from one or a mixture of toluene, cyclohexane, xylene, chlorobenzene, n-hexane, petroleum ether, n-heptane, methyl tert-butyl ether, isopropyl ether, n-butyl ether, ethyl ether, tetrahydrofuran, methyltetrahydrofuran, ethyl acetate, methyl formate, ethyl formate, methyl acetate, isopropyl acetate, tert-butyl acetate, butyl acetate, ethyl propionate, methyl propionate, methyl benzoate, butyl chloride, chloropentane, chlorocyclopentane, hexyl chloride, chlorocyclohexane, acetone, butanone, pentanone, cyclohexanone, etc.
本发明的另一目的是提供所述精制1,5-戊二醇的制备方法,其包括如下步骤:Another object of the present invention is to provide a method for preparing the refined 1,5-pentanediol, which comprises the following steps:
将结构式为III的粗制1,5-戊二醇与结构式为V的对硝基苯甲酸在酸催化下进行缩合反应得到式VI化合物,然后在碱性条件下发生水解反应得到精制1,5-戊二醇。The crude 1,5-pentanediol of structural formula III and p-nitrobenzoic acid of structural formula V are subjected to a condensation reaction under acid catalysis to obtain a compound of formula VI, and then a hydrolysis reaction is carried out under alkaline conditions to obtain refined 1,5-pentanediol.
优选地,所述酸选自苯磺酸、甲磺酸、硫酸等中的一种或多种Preferably, the acid is selected from one or more of benzenesulfonic acid, methanesulfonic acid, sulfuric acid, etc.
优选地,所述碱性条件为氢氧化钠、氢氧化钾、碳酸钠、碳酸钾的一种或多种的存在下。Preferably, the alkaline condition is the presence of one or more of sodium hydroxide, potassium hydroxide, sodium carbonate and potassium carbonate.
纯化后1,5-戊二醇的纯度高达99.8%,单一杂质的含量控制在0.06%以下,从源头上有效的控制了杂质的产生。After purification, the purity of 1,5-pentanediol is as high as 99.8%, and the content of a single impurity is controlled below 0.06%, effectively controlling the generation of impurities from the source.
有益效果Beneficial Effects
本发明提供的方法,于缩合反应共沸分水的后期在分水器中使用分子筛吸收产生的少量水分,促进反应进行完全。相比于其他公开的方法,此方法的优点在于:脱水剂用量少,不进入反应体系,易于分离,操作简便。The method provided by the present invention uses a molecular sieve in a water separator to absorb a small amount of water generated in the late stage of azeotropic water separation of the condensation reaction, thereby promoting the reaction to proceed completely. Compared with other disclosed methods, this method has the advantages of: less dehydrating agent is used, does not enter the reaction system, is easy to separate, and is simple to operate.
本发明提供的使用精制1,5-戊二醇和苯磺酸一水合物制备顺苯磺酸阿曲库铵的方法避免了市售戊二醇中的杂质参与反应,避免的难以除去的杂质的生成,纯化步骤大大简化,避免了纯化环节中大量溶剂的使用与耗费,产品质量稳定,总收率及产品纯度得到明显提高。The method for preparing atracurium besylate by using refined 1,5-pentanediol and benzenesulfonic acid monohydrate provided by the present invention avoids the impurities in commercially available pentanediol from participating in the reaction, avoids the generation of impurities that are difficult to remove, greatly simplifies the purification steps, avoids the use and consumption of a large amount of solvents in the purification link, stabilizes the product quality, and significantly improves the total yield and product purity.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为实施例1中反应液HPLC图谱;Fig. 1 is a HPLC spectrum of the reaction solution in Example 1;
图2为实施例1中得到的产品固体I的HPLC图谱;Fig. 2 is the HPLC spectrum of the product solid I obtained in Example 1;
图3为实施例2中反应液HPLC图谱;Fig. 3 is the HPLC spectrum of the reaction solution in Example 2;
图4为实施例2中得到的产品固体I的HPLC图谱;FIG4 is an HPLC spectrum of the solid product I obtained in Example 2;
图5为实施例3中纯化前的粗制1,5-戊二醇及纯化后的精制1,5-戊二醇GC检测谱图;FIG5 is a GC detection spectrum of crude 1,5-pentanediol before purification and refined 1,5-pentanediol after purification in Example 3;
图6为实施例3中纯化后的精制1,5-戊二醇GC检测谱图;FIG6 is a GC detection spectrum of purified 1,5-pentanediol after purification in Example 3;
图7为实施例4中得到的产品固体I的HPLC图谱。FIG. 7 is an HPLC spectrum of the product solid I obtained in Example 4.
具体实施方式Detailed ways
通过下列实施例说明本发明的实施方案。然而,应了解本发明的实施方案不受限于下列实施例中的特定细节,因为鉴于本发明的公开内容,其他变化对本领域普通技术人员是已知和显而易见的。实施例中用到的精制1,5-戊二醇由实施例3制备得到。The following examples illustrate embodiments of the present invention. However, it should be understood that embodiments of the present invention are not limited to the specific details in the following examples, as other variations are known and obvious to those of ordinary skill in the art in view of the disclosure of the present invention. The refined 1,5-pentanediol used in the examples was prepared by Example 3.
实施例1:Embodiment 1:
将化合物II(10g,17.0mmol,1eq),精制1,5-戊二醇(0.842g,8.1mmol,0.475eq,GC纯度99.8%,单杂均小于0.10%),苯磺酸一水合物(6.29g,35.7mmol)加入到二氯甲烷(150ml)中,加热回流分水5-6小时,在分水器中加入4A球型分子筛(10g),继续回流分水15小时,HPLC检测(反应液纯度93%),将加热停止,冷却到室温后,加入水洗4次(50ml*4),分层后将二氯甲烷层减压浓缩至小体积,滴加入甲苯(50ml)中,搅拌,过滤,烘干得到固体化合物I(9g),摩尔收率约89%(以精制1,5-戊二醇完全转化的收率计算),产品纯度99.5%。Compound II (10 g, 17.0 mmol, 1 eq), refined 1,5-pentanediol (0.842 g, 8.1 mmol, 0.475 eq, GC purity 99.8%, single impurity less than 0.10%), benzenesulfonic acid monohydrate (6.29 g, 35.7 mmol) were added to dichloromethane (150 ml), heated to reflux and separate water for 5-6 hours, 4A spherical molecular sieves (10 g) were added to the water separator, reflux and separate water for 15 hours, HPLC detection (reaction liquid purity 93%), heating was stopped, cooled to room temperature, and washed with water 4 times (50 ml*4), after layering, the dichloromethane layer was concentrated to a small volume under reduced pressure, added dropwise to toluene (50 ml), stirred, filtered, and dried to obtain solid compound I (9 g), with a molar yield of about 89% (calculated based on the yield of complete conversion of refined 1,5-pentanediol), and a product purity of 99.5%.
反应液HPLC图谱如图1所示。固体HPLC图谱如图2所示。The HPLC spectrum of the reaction liquid is shown in Figure 1. The HPLC spectrum of the solid is shown in Figure 2.
实施例2:Embodiment 2:
将化合物II(10g,17.0mmol,1eq),市售1,5-戊二醇(0.842g,8.1mmol,0.475eq),苯磺酸一水合物(6.29g,35.7mmol)加入到二氯甲烷(150ml)中,加热回流分水5小时,在分水器中加入4A球型分子筛(10g),继续回流分水15小时,HPLC检测(反应液纯度88%),停止加热,冷却到室温后,加入水洗4次(50ml*4),分层后将二氯甲烷层减压浓缩至小体积,加入至甲苯(50ml)中,搅拌,过滤,得到化合物I(9g),摩尔收率90%,产品纯度94.3%。Compound II (10 g, 17.0 mmol, 1 eq), commercially available 1,5-pentanediol (0.842 g, 8.1 mmol, 0.475 eq), and benzenesulfonic acid monohydrate (6.29 g, 35.7 mmol) were added to dichloromethane (150 ml), and the mixture was heated to reflux and separated for 5 hours. 4A spherical molecular sieves (10 g) were added to the water separator, and reflux and separated for 15 hours. HPLC detection (reaction liquid purity 88%) was performed, and the heating was stopped. After cooling to room temperature, water was added and washed 4 times (50 ml*4). After stratification, the dichloromethane layer was concentrated under reduced pressure to a small volume, added to toluene (50 ml), stirred, and filtered to obtain compound I (9 g) with a molar yield of 90% and a product purity of 94.3%.
反应液HPLC图谱如图3所示。固体HPLC纯度如图4所示。The HPLC spectrum of the reaction liquid is shown in Figure 3. The HPLC purity of the solid is shown in Figure 4.
实施例3:Embodiment 3:
市售的粗制1,5-戊二醇(0.5eq)和对硝基苯甲酸(1eq)加入到甲苯中,在苯磺酸(5%)的催化下回流分水,反应完后,停止加热,将固体缓慢降温析晶,过滤,固体加入到THF和氢氧化钠和水溶液中加热水解,反应完后,用浓硫酸调节PH到3-4,将固体过滤,滤液浓缩至小体积后加入THF打浆,将盐过滤,滤液减压浓缩将水浓缩干,再将产品蒸出,收率70-80%,GC纯度99.88%。Commercially available crude 1,5-pentanediol (0.5 eq) and p-nitrobenzoic acid (1 eq) are added to toluene, refluxed and separated under the catalysis of benzenesulfonic acid (5%). After the reaction is completed, the heating is stopped, the solid is slowly cooled and crystallized, filtered, and the solid is added to THF and sodium hydroxide and aqueous solution and heated for hydrolysis. After the reaction is completed, the pH is adjusted to 3-4 with concentrated sulfuric acid, the solid is filtered, the filtrate is concentrated to a small volume and THF is added for pulping, the salt is filtered, the filtrate is concentrated under reduced pressure to concentrate the water to dryness, and then the product is evaporated, with a yield of 70-80% and a GC purity of 99.88%.
纯化前粗制1,5-戊二醇及纯化后的精制1,5-戊二醇GC检测谱图如图5所示。The GC detection spectra of crude 1,5-pentanediol before purification and refined 1,5-pentanediol after purification are shown in FIG5 .
纯化后精制1,5-戊二醇GC检测谱图如图6所示。The GC detection spectrum of purified 1,5-pentanediol is shown in Figure 6.
实施例4:Embodiment 4:
将化合物II(10g,17.0mmol,1eq),精制1,5-戊二醇(0.842g,8.1mmol,0.475eq),苯磺酸一水合物(6.29g,35.7mmol)加入到甲苯(150ml)中,加热回流分水5小时,在分水器中加入无水硫酸钠(10g),继续回流分水15小时,HPLC检测反应完后,将加热停止,冷却到室温后,加入水洗4次(50ml*4),分层后将二氯甲烷层减压浓缩至小体积,滴加入甲基叔丁基醚,搅拌,析出固体,过滤,烘干,得到固体化合物I(9g),摩尔收率约89%,产品纯度98.7%。Compound II (10 g, 17.0 mmol, 1 eq), refined 1,5-pentanediol (0.842 g, 8.1 mmol, 0.475 eq), and benzenesulfonic acid monohydrate (6.29 g, 35.7 mmol) were added to toluene (150 ml), heated to reflux and separate water for 5 hours, anhydrous sodium sulfate (10 g) was added to the water separator, and reflux and separate water for 15 hours. After HPLC detection, the heating was stopped, and after cooling to room temperature, water was added and washed 4 times (50 ml*4). After layering, the dichloromethane layer was concentrated to a small volume under reduced pressure, methyl tert-butyl ether was added dropwise, stirred, a solid was precipitated, filtered, and dried to obtain solid compound I (9 g) with a molar yield of about 89% and a product purity of 98.7%.
固体HPLC谱图如图7所示。The solid HPLC spectrum is shown in Figure 7.
实施例5:Embodiment 5:
将化合物II(10g,17.0mmol,1eq),市售1,5-戊二醇(0.842g,8.1mmol,0.475eq),苯磺酸一水合物(6.29g,35.7mmol)加入到甲苯(150ml)中,加热回流分水5小时,在分水器中加入无水硫酸钠(10g),继续回流分水15小时,HPLC检测反应完后,将加热停止,冷却到室温后,加入水洗4次(50ml*4),分层后将二氯甲烷层减压浓缩至小体积,滴加入环己酮(50ml),搅拌,析出固体,过滤,烘干,得到固体化合物I(9g),摩尔收率约90%,产品纯度95.7%。Compound II (10 g, 17.0 mmol, 1 eq), commercially available 1,5-pentanediol (0.842 g, 8.1 mmol, 0.475 eq), and benzenesulfonic acid monohydrate (6.29 g, 35.7 mmol) were added to toluene (150 ml), heated to reflux and separate water for 5 hours, anhydrous sodium sulfate (10 g) was added to the water separator, and reflux and separate water for 15 hours. After HPLC detection, the heating was stopped, and after cooling to room temperature, water was added and washed 4 times (50 ml*4). After stratification, the dichloromethane layer was concentrated to a small volume under reduced pressure, and cyclohexanone (50 ml) was added dropwise, stirred, and a solid was precipitated. The solid was filtered and dried to obtain a solid compound I (9 g) with a molar yield of about 90% and a product purity of 95.7%.
实施例6:Embodiment 6:
将化合物II(10g,17.0mmol,1eq),市售1,5-戊二醇(0.842g,8.1mmol,0.475eq),苯磺酸一水合物(6.29g,35.7mmol)加入到乙酸乙酯(150ml)中,加热回流分水5小时,在分水器中加入无水氯化钙(10g),继续回流分水15小时,HPLC检测反应完后,将加热停止,冷却到室温后,加入水洗4次(50ml*4),分层后将二氯甲烷层减压浓缩至小体积,滴加入正己烷(50ml),搅拌,析出固体,过滤,烘干,得到固体化合物I(9g),摩尔收率约90%,产品纯度91.8%。Compound II (10 g, 17.0 mmol, 1 eq), commercially available 1,5-pentanediol (0.842 g, 8.1 mmol, 0.475 eq), and benzenesulfonic acid monohydrate (6.29 g, 35.7 mmol) were added to ethyl acetate (150 ml), heated to reflux and separate water for 5 hours, anhydrous calcium chloride (10 g) was added to the water separator, and reflux and separate water for 15 hours. After HPLC detection, the heating was stopped, and after cooling to room temperature, water was added and washed 4 times (50 ml*4). After stratification, the dichloromethane layer was concentrated to a small volume under reduced pressure, and n-hexane (50 ml) was added dropwise, stirred, and a solid was precipitated. It was filtered and dried to obtain a solid compound I (9 g) with a molar yield of about 90% and a product purity of 91.8%.
上述例子仅作为说明的目的,本发明的范围并不受此限制。对本领域的技术人员来说进行修改是显而易见的,本发明仅受所附权利要求范围的限制。The above examples are for illustrative purposes only, and the scope of the present invention is not limited thereby. Modifications will be apparent to those skilled in the art, and the present invention is limited only by the scope of the appended claims.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910491476.2A CN112047883B (en) | 2019-06-06 | 2019-06-06 | Preparation method of atracurium besylate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910491476.2A CN112047883B (en) | 2019-06-06 | 2019-06-06 | Preparation method of atracurium besylate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112047883A CN112047883A (en) | 2020-12-08 |
| CN112047883B true CN112047883B (en) | 2024-04-19 |
Family
ID=73609600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910491476.2A Active CN112047883B (en) | 2019-06-06 | 2019-06-06 | Preparation method of atracurium besylate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112047883B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113372271A (en) * | 2020-12-24 | 2021-09-10 | 上海药坦药物研究开发有限公司 | Preparation method of cisatracurium besylate |
| CN112778200B (en) * | 2021-01-20 | 2022-09-23 | 江苏诚信药业有限公司 | Preparation method and application of cisatracurium besilate |
| CN115947685A (en) * | 2023-02-07 | 2023-04-11 | 山东铂源药业股份有限公司 | Preparation method of chiral isomer impurity of cisatracurium besylate |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3010510A1 (en) * | 1979-03-23 | 1980-10-02 | Basf Wyandotte Corp | Purifying diol by treatment with sulphonic acid - for prodn. of polyester poly:ol(s) etc. of better colour |
| JP2004238340A (en) * | 2003-02-07 | 2004-08-26 | Idemitsu Petrochem Co Ltd | High-purity alkane-1,2-diol and method for producing the same |
| WO2009007946A1 (en) * | 2007-07-09 | 2009-01-15 | Chemagis Ltd. | Process for producing cisatracurium and associated intermediates |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7084311B2 (en) * | 2003-05-06 | 2006-08-01 | E. I. Du Pont De Nemours And Company | Hydrogenation of chemically derived 1,3-propanediol |
-
2019
- 2019-06-06 CN CN201910491476.2A patent/CN112047883B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3010510A1 (en) * | 1979-03-23 | 1980-10-02 | Basf Wyandotte Corp | Purifying diol by treatment with sulphonic acid - for prodn. of polyester poly:ol(s) etc. of better colour |
| JP2004238340A (en) * | 2003-02-07 | 2004-08-26 | Idemitsu Petrochem Co Ltd | High-purity alkane-1,2-diol and method for producing the same |
| WO2009007946A1 (en) * | 2007-07-09 | 2009-01-15 | Chemagis Ltd. | Process for producing cisatracurium and associated intermediates |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112047883A (en) | 2020-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112047883B (en) | Preparation method of atracurium besylate | |
| CN112174798A (en) | Synthesis method of Sacubitril valsartan sodium LCZ696 | |
| CN110305018B (en) | Preparation method of 3-bromo-2-fluoronitrobenzene | |
| CN108623456A (en) | The preparation method of butylphenyl phthaleine and its pharmaceutical intermediate | |
| CN110590587A (en) | Synthetic method of 3-chloro-L-alanine methyl ester hydrochloride | |
| CN103641686B (en) | Synthetic method of 2,3,5,6-tetrafluoro-1,4-benzenedimethanol | |
| CN101012147A (en) | Method of preparing R-(+)-3-chlorophenylpropanol | |
| CN102267961B (en) | Method for preparing ethyl (3R,4R,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-1-cyclohexene-1-formate | |
| CN108440409B (en) | Green and efficient preparation method of rebamipide | |
| CN103242186B (en) | Combined production method of methacrylamide and methyl methacrylate | |
| CN105001098A (en) | Method for preparing 3(R)/(S)-amidogen-1-butanol | |
| CN113234030B (en) | A preparation method of 6-bromo-3-hydroxy-2-pyrazinecarboxamide | |
| CN101182285B (en) | The manufacture method of p-chlorobenzyl alcohol | |
| CN104496892A (en) | Novel technology for synthesizing 4-dimethylamino-pyridine | |
| CN116693437A (en) | Synthesis method of N-Boc-3-azetidineacetic acid | |
| CN116640057B (en) | A method for preparing 4,4'-diacyl chloride diphenyl ether | |
| CN115466302A (en) | Synthesis and purification method of abiraterone acetate | |
| CN109651234B (en) | Synthesis method of donepezil hydrochloride | |
| CN114671859A (en) | Preparation method of rosuvastatin calcium and intermediate thereof | |
| CN114539100A (en) | Terbutaline derivative D and preparation method and application thereof | |
| CN116514716B (en) | Preparation method of (S) -1, 3-dihydro spiro [ indene-2, 4' -piperidine ] -1-amine-dihydrochloride | |
| CN103130729B (en) | Preparation method of 4-chloro-7-methoxyl quinazoline-6-alchol acetate | |
| CN110143861A (en) | A kind of preparation method of ibuprofen | |
| CN119591653B (en) | Synthesis method of 5 alpha-androstane-2-alkene-17-ketone | |
| CN111635325A (en) | A kind of method for preparing metoprolol succinate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250822 Address after: 262123 No. 49 Wen Bei Road, Anqiu Economic Development Zone, Shandong, Weifang Patentee after: TOPHARMAN SHANDONG Co.,Ltd. Country or region after: China Patentee after: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Address before: Building 1, Lane 388, Galileo Road, Zhangjiang hi tech park, Pudong New Area, Shanghai, 201203 Patentee before: TOPHARMAN SHANGHAI Co.,Ltd. Country or region before: China Patentee before: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES |
|
| TR01 | Transfer of patent right |